Zum Hauptinhalt springen
Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Venture Investing in Science - Douglas Jamison, Stephen Waite

Venture Investing in Science

Buch | Hardcover
304 Seiten
2017
Columbia University Press (Verlag)
9780231175722 (ISBN)
CHF 52,35 inkl. MwSt
How venture capital spurs scientific discovery, and what we miss when we don’t invest.
Over the past decade, software companies have increasingly monopolized the flow of venture capital, starving support for scientific research and its transformative discoveries. New medicines, cheaper and faster personal computers, and other life-changing developments all stem from investment in science. In the past, these funds led to steam engines, light bulbs, microprocessors, 3D printers, and even the Internet. In Venture Investing in Science, the venture capitalist Douglas W. Jamison and the investment author Stephen R. Waite directly link financial support to revolutionary advancements in physics, computers, chemistry, and biology and make a passionate case for continued investing in science to meet the global challenges of our time. Clean air and water, cures for intractable diseases, greener public transportation, cheaper and faster communication technologies-these are some of the rich opportunities awaiting venture capital investment today.
Jamison and Waite focus on how early-stage companies specializing in commercializing transformative technologies based on deep science have been shunned by venture capitalists, and how the development of such companies have been hampered by structural changes in capital markets and government regulation over the past decade. The authors argue that reinvigorating science-based technological innovation is crucial to reactivating the economic dynamism that lifts living standards and fuels prosperity over time.

Douglas W. Jamison is the chairman and CEO of HALE.life, a privately held precision health and medicine operating company in which Harris & Harris Group is an investor. Previously he was chairman and CEO of Harris & Harris Group, a publicly traded company that makes early-stage venture capital investments in science-based companies. Stephen R. Waite works as a strategic advisor and investment manager. He is the author of Quantum Investing (2003) and coauthor of Boomernomics (1998).

Foreword, by Mark Anderson Preface Acknowledgments Introduction 1. Deep Science Disruption 2. The U.S. Deep Science Innovation Ecosystem 3. Deep Science and the Evolution of American Venture Capital 4. Diversity Breakdown in Venture Investing 5. Fostering Diversity in Venture Investing 6. Deep Science Venture Investing 7. Our Choice Ahead Appendix 1: The Case of D-Wave Systems Appendix 2: The Case of Nantero Notes Index

Erscheinungsdatum
Zusatzinfo 47 figures
Verlagsort New York
Sprache englisch
Maße 152 x 229 mm
Themenwelt Naturwissenschaften
Wirtschaft Betriebswirtschaft / Management Finanzierung
ISBN-13 9780231175722 / 9780231175722
Zustand Neuware
Informationen gemäß Produktsicherheitsverordnung (GPSR)
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
Allgemeines Steuerrecht, Abgabenordnung, Umsatzsteuer

von Manfred Bornhofen; Martin C. Bornhofen

Buch (2025)
Springer Gabler (Verlag)
CHF 39,20